Evidence map›Paper›PMID 37258209›Full record

ReviewInternal medicine (Tokyo, Japan)2023

Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature.

Yasutaka Masuda, Takashi Oyama, Kumi Nakazaki, Yudai Nakai, Ken Sasaki, Kensuke Matsuda, Yosuke Masamoto, Mineo Kurokawa

Open access · diamondAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. G-CSF-induced Aortitis Mimicking TIPIC Syndrome.Internal medicine (Tokyo, Japan) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yasutaka MasudaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Takashi OyamaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Kumi NakazakiDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Yudai NakaiDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, Japan.
Ken SasakiDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Kensuke MatsudaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Yosuke MasamotoDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Mineo KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report an 83-year-old woman with filgrastim-associated aortitis during chemotherapy for relapsed diffuse large B-cell lymphoma. She had been treated with filgrastim as a prophylaxis for neutropenia during the fourth cycle of chemotherapy from day 9 to 18. On day 21, she developed a fever. Contrast-enhanced computed tomography revealed aortitis of the descending aorta. The fever abated with non-steroidal anti-inflammatory drug treatment. A literature review identified a small number of aortitis cases all caused by prophylactic use of granulocyte colony-stimulating factors (G-CSFs), among which short-acting filgrastim was rarely encountered. The present and previous findings imply a possible relationship between aortitis and prophylactic G-CSF usage.

Indexed as

AortitisNeoplasmsNeutropeniaAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleFeverFilgrastimGranulocyte Colony-Stimulating FactorHumansFilgrastimGranulocyte Colony-Stimulating Factoraortitisgranulocyte colony-stimulating factorlong-acting G-CSFnon-Hodgkin lymphomaprophylactic treatmentshort-acting G-CSF

Identifiers

PMID37258209
PMCPMC10292992
OpenAlexW4378801316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.